News
Exploring a New Targeted Therapy
UCSF Shares Promising Results of a Clinical Trial At the 2019 meeting of the American Cancer Society of Clinical Oncologists (ASCO), Emily Bergsland, MD, University
FAQs Neuroendocrine Tumor Tissue Donation
The need for tumor tissue in NETs The Neuroendocrine Tumor Research Foundation is on a mission to fill the urgent need for more neuroendocrine tumor
NETRF 2019 Research Symposium
Latest in NET Cancer Research Neuroendocrine Tumor Research Foundation (NETRF) held its 11th Annual Research Symposium on May 2-3, 2019, in Cambridge, MA. More than
2019 NET Research Grants
NETRF Announces 2019 Neuroendocrine Cancer Research Funding Opportunities New award to fund early career investigators The Neuroendocrine Tumor Research Foundation (NETRF) has announced a new
Developing a NET Cell Line
NETRF & Broad Institute Work to Fill Research Void The lack of publicly available, reliable NET cell lines is a barrier in neuroendocrine tumor research,
Exploring Targeted Alpha Therapy for Neuroendocrine Tumors
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.
Dr. Mark Lewis Joins Board
Mark A. Lewis, MD, Director of Gastrointestinal Oncology, Intermountain Healthcare, Utah, has joined the Board of Directors for the Neuroendocrine Tumor Research Foundation. Dr. Lewis,
Gold Seal GuideStar
NETRF given the highest ranking for financial responsibility and transparency by leading nonprofit rating program, GoldStar.
Celebrating NET Specialists on Doctors Day 2019
NETRF is so pleased to report that we received several gifts honoring many NET doctors around the country on March 30th, National Doctor’s Day! Thank
New Mentored Award to Help Launch NET Careers
The Neuroendocrine Tumor Research Foundation (NETRF) announces a new NETRF Mentored Award for early career researchers, supported by Ipsen. The two-year grant for those in